Help Navigate Common Hurdles With GLP-1 Agonists

February 2024

Questions are rolling in about GLP-1 agonists...dulaglutide (Trulicity), liraglutide (Victoza), semaglutide (Ozempic,etc), etc.

It’s partly because these meds are a first-line option for type 2 diabetes with compelling indications...such as CV or kidney disease.

Plus semaglutide or the dual agonist tirzepatide (Zepbound,etc) seem to be the most effective meds for managing overweight or obesity.

Get concise advice on drug therapy, plus unlimited access to CE

Hospital Pharmacist's Letter membership benefits include:

  • 12 issues every year — what you need to know and do, right now
  • Quick, practical reference charts and tools
  • Comprehensive CE library to meet license renewal and state requirements
  • Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
  • Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote